Versartis, Inc.
contact us
  • home
  • about us
  • leadership
  • technology
  • product pipeline
  • partners and licensing
  • news and events
 
  • Overview
  • VRS-317

Pipeline

Overview

 
  Pre-clinical IND Phase 1 Phase 2 Phase 3 Approved
             

Growth Deficiency

            

VRS-317 (hGH)
[adult]

       

VRS-317 (hGH)
[pediatric]

       
             

Undisclosed

            

Undisclosed

          

 

 

  
     
Copyright © 2010 Versartis, Inc.